NEW YORK (GenomeWeb News) — Medical Solutions plans to buy Geneservice for ₤3.9 million ($7.6 million), Medical Solutions said in a statement on Thursday.
 
Geneservice, a 2005 spinout of the UK’s Medical Research Council, provides genomics services, such as qPCR, to academic and corporate clients.
 
Medical Solutions said it is looking to expand its diagnostic and prognostic tests, and said it believes qPCR will be “the favored technology” for many diagnostics in five to 10 years.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.